Invention Grant
- Patent Title: AAV delivery of shRNA for treatment of pancreatic cancer
-
Application No.: US16347461Application Date: 2017-11-03
-
Publication No.: US11781142B2Publication Date: 2023-10-10
- Inventor: Maria Zajac-Kaye , Kyungah Maeng
- Applicant: University of Florida Research Foundation, Incorporated
- Applicant Address: US FL Gainesville
- Assignee: University of Florida Research Foundation, Incorporated
- Current Assignee: University of Florida Research Foundation, Incorporated
- Current Assignee Address: US FL Gainesville
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2017/059843 2017.11.03
- International Announcement: WO2018/132155A 2018.07.19
- Date entered country: 2019-05-03
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C12N15/864 ; A61P35/00 ; C12N7/00 ; A01K67/027
Abstract:
Aspects of the disclosure relate to methods and compositions for treating pancreatic cancer (e.g., islet cell tumors). In some aspects, adeno-associated virus (AAV) may be used to deliver an interfering RNA that targets thymidylate synthase (TS).
Public/Granted literature
- US20190256858A1 AAV DELIVERY OF SHRNA FOR TREATMENT OF PANCREATIC CANCER Public/Granted day:2019-08-22
Information query
IPC分类:
